Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening

European Journal of Haematology

Volumn 96, Issue 6, 2016, Pages 578-585

  Li, Rong ^a   Swaelens, Caroline ^a   Vandermijnsbrugge, Francine ^a   Cantinieaux, Brigitte ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

ActinFS; Factor deficiency; Mixing study; Pre operative screening; Prolonged activated partial thromboplastin time

Indexed keywords

ACTINFS; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; LUPUS ANTICOAGULANT; PLATELINLS; REAGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLEEDING; BLEEDING RELATED FACTOR DEFICIENCY; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; COAGULATION PROTEIN DISORDERS; NEWBORN; PREOPERATIVE CARE; PRESCHOOL CHILD; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; COAGULATION PROTEIN DISORDERS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LUPUS COAGULATION INHIBITOR; MALE; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84938149203     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12634     Document Type: Article

References (27)

1. Olson JD. Abnormal activated partial thromboplastin time. An algorithmic approach to hemostasis testing, Kottke-Marchant K. Northfried, IL: College of American pathologists (CAP); 2008:143-51
2. Kaplan EB, Sheiner LB, Boeckmann AJ, Roizen MF, Beal SL, Cohen SN, Nicoll CD. The usefulness of preoperative laboratory screening. JAMA 1985;253:3576-81.
3. Suchman AL, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage?. JAMA 1986;256:750-3.
4. Close HL, Kryzer TC, Nowlin JH, Alving BM. Hemostatic assessment of patients before tonsillectomy: a prospective study. Otolaryngol Head Neck Surg 1994;111:733-8.
5. Howells RC, Wax MK, Ramadan HH. Value of preoperative prothrombin time/partial thromboplastin time as a predictor of postoperative hemorrhage in pediatric patients undergoing tonsillectomy. Otolaryngol Head Neck Surg 1997;117:628-32.
6. Asaf T, Reuveni H, Yermiahu T, Leiberman A, Gurman G, Porat A, Schlaeffer P, Shifra S, Kapelushnik J. The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol 2001;61:217-22.
7. Shah MD, O'Riordan MA, Alexender SW. Evaluation of prolonged aPTT values in the pediatric population. Clin Pediatr 2006;45:347-53.
8. Scheckenbach K, Bier H, Hoffmann TK, Windfuhr JP, Bas M, Laws HJ, Plettenberg C, Wagenmann M. Risk of hemorrhage after adenoidectomy and tonsillectomy. Value of the preoperative determination of partial thromboplastin time, prothrombin time and platelet count. HNO 2008;56:312-20.
9. Sandoval C, Dong S, Visintainer P, Ozkaynak MF, Jayabose S. Clinical and laboratory features of 178 children with recurrent epistaxis. J Pediatr Hematol Oncol 2002;24:47-9.
10. Elden L, Reinders M, Witmer C. Predictors of bleeding disorders in children with epistaxis: value of preoperative tests and clinical screening. Int J Pediatr Otorhinolaryngol 2012;76:767-71.
11. Sandoval C, Garcia C, Visintainer P, Ozkaynak MF, Jayabose S. The usefulness of preoperative screening for bleeding disorders. Clin Pediatr 2003;42:247-50.
12. Ledford-Kraemer MR. Laboratory testing for lupus anticoagulants: preexamination variables, mixing studies and diagnostic criteria. Samin Thromb Hemost 2008;34:380-8.
13. Brancaccio V, Ames PR, Glynn J, Iannaccone L, Mackie IJ. A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent. Blood Coagul Fibrinolysis 1997;8:155-60.
14. Cruickshank MK, Black J, Stuart RK. Insensitivity of actin FS in the detection of nonspecific inhibitors. Arch Pathol Lab Med 1994;118:9.
15. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Production of an aPTT discriminant function for the detection of lupus anticoagulant. Sysmex J Int 1996;6:164-7.
16. Lawrie AS, Kitchen S, Purdy G, Mackie IJ, Preston FE, Machin SJ. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies. Clin Lab Haematol 1998;20:179-86.
17. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisloff F. The Lupus Ratio test: an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semiquantitative test. Fifth International Survey of Lupus Anticoagulants ISLA 5. Thromb Haemost 2000;83:704-8.
18. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012;157:47-58.
19. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:1737-40.
20. Wians FH. Clinical laboratory tests: which, why, and what do the results mean? LabMed 2009;40:105-13.
21. Jennings I, Kitchen DP, Kitchen S, Woods TAL, Walker ID. Investigation of a prolonged APTT. Different approaches taken by laboratories to achieve the same diagnosis. Int J Lab Hematol 2013;35:177-82.
22. Dembitzer FR, Suarez Y, Aledort LM, Peerschke EI. Screening coagulation testing using the APTT: which reagent to choose? Am J Hematol 2010;85:726.
23. Fritsma GA, Dembitzer FR, Randhawa A, Marques MB, Van Cott EM, Adcock-Funk D, Peerschke EI. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization. Am J Clin Pathol 2012;137:904-8.
24. Bowyer A, Kitchen S, Kakris M. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies. Int J Lab Hematol 2011;33:154-8.
25. Bowyer A, Smith J, Woolley AM, Kitchen S, Hampton KK, Maclean RM, Van Veen JJ, Kakris M. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal. Int J Lab Hematol 2011;33:212-8.
26. Turi DC, Peerschke EI. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies. Am J Clin Pathol 1986;85:43-9.
27. Lawrie AS, Kitchen S, Efthymiou M, Mackie IJ, Machin SJ. Determination of APTT factor sensitivity - the misguiding guideline. Int J Lab Hematol 2014;35:652-7.